New Data at AHS Annual Meeting Demonstrate Substantial Results for Patients Using Neurolief’s Digital Therapeutics Technology to Treat Migraine

TAMPA, Fla., June 20, 2023 /PRNewswire/ — Neurolief, a medical neurotechnology innovator, today announced new data released at the 65th Annual Scientific Meeting hosted by the American Headache Society (June 15-18, 2023, Austin, TX). The real-world, open label analysis presents…

Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks